{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:00:15Z","timestamp":1792202415251,"version":"4.4.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>\n                    Nuclear protein in testis gene rearrangement-associated midline carcinoma (NUT carcinoma) is a rare and highly invasive tumor. Here, we are reporting the image findings of a 38-year-old woman with lung NUT carcinoma. To evaluate the bone metastases, she underwent\n                    <jats:sup>68<\/jats:sup>\n                    Ga-labeled DOTA-ibandronic acid (\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTA-IBA) PET\/CT examination. Surprisingly, the patient\u2019s lung primary focus and subcutaneous nodule on the left side of the lower back region showed increased uptake.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005902","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T01:00:10Z","timestamp":1744938010000},"page":"1074-1075","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Increased Uptake of 68Ga-DOTA-IBA in Lung NUT Carcinoma"],"prefix":"10.1097","volume":"50","author":[{"given":"Na","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huipan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-7649","authenticated-orcid":false,"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"R1-20251009","doi-asserted-by":"crossref","first-page":"102826","DOI":"10.1016\/j.critrevonc.2019.102826","article-title":"NUT midline carcinoma: current concepts and future perspectives of a novel tumour entity","volume":"144","author":"Salati","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"R2-20251009","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bulcan.2022.01.015","article-title":"NUT carcinoma in children, adolescents and young adults","volume":"109","author":"Lemelle","year":"2022","journal-title":"Bull Cancer"},{"key":"R3-20251009","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1002\/cam4.4096","article-title":"Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma","volume":"10","author":"Xie","year":"2021","journal-title":"Cancer Med"},{"key":"R4-20251009","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.semdp.2021.06.005","article-title":"NUT carcinoma of the lung","volume":"38","author":"Lantuejoul","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"R5-20251009","doi-asserted-by":"crossref","first-page":"101640","DOI":"10.1016\/j.tranon.2023.101640","article-title":"Nuclear protein in testis carcinoma of the lung","volume":"30","author":"Chen","year":"2023","journal-title":"Transl Oncol"},{"key":"R6-20251009","doi-asserted-by":"crossref","first-page":"1364311","DOI":"10.3389\/fonc.2024.1364311","article-title":"Comparison of the relative diagnostic performance of 68Ga-DOTA-IBA and 18F-NaF for the detection of bone metastasis","volume":"14","author":"Deng","year":"2024","journal-title":"Front Oncol"},{"key":"R7-20251009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13550-024-01094-6","article-title":"Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases","volume":"14","author":"Li","year":"2024","journal-title":"EJNMMI Res"},{"key":"R8-20251009","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/acs.molpharmaceut.2c00978","article-title":"Lutetium177-labeled DOTA-ibandronate: a novel radiopharmaceutical for targeted treatment of bone metastases","volume":"20","author":"Wang","year":"2023","journal-title":"Mol Pharm"},{"key":"R9-20251009","doi-asserted-by":"crossref","first-page":"1027792","DOI":"10.3389\/fonc.2022.1027792","article-title":"Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"R10-20251009","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/RLU.0000000000004634","article-title":"Safety and efficacy of 68Ga- or 177Lu-labeled DOTA-IBA as a novel theranostic radiopharmaceutical for bone metastases: a phase 0\/I study","volume":"48","author":"Qiu","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R11-20251009","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/RLU.0000000000005462","article-title":"Increased uptake of 68Ga-DOTA-IBA in multiple subcutaneous metastases of prostate cancer","volume":"49","author":"Liu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R12-20251009","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/RLU.0000000000005415","article-title":"Incidental uptake of 68Ga-DOTA-IBA in prostate adenocarcinoma","volume":"49","author":"Liu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R13-20251009","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/RLU.0000000000005200","article-title":"68Ga-DOTA-IBA uptake in breast cancer","volume":"49","author":"Xiang","year":"2024","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:03:50Z","timestamp":1760025830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005902","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"2025-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}